Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. 10-K Report Annual Report
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Option exercise SVP, Research acquired 55,234 shares (option exercise)
  10. SC 13G Stake Amended Statement of Ownership
  11. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  17. SC 13G Stake Amended Statement of Ownership
  18. 8-K Event Agreement ended
  19. 8-K Event Other events
  20. SC 13D/A Stake Beneficial Ownership Report

Page 16 of 20 · 400 filings